168 related articles for article (PubMed ID: 7503375)
21. Cholesteatoma in children: histopathologic findings in middle ear ossicles.
Quaranta A; Bartoli R; Lozupone E; Resta L; Iurato S
ORL J Otorhinolaryngol Relat Spec; 1995; 57(5):296-8. PubMed ID: 8587786
[TBL] [Abstract][Full Text] [Related]
22. Fascin expression in cholesteatoma: correlation with destruction of the ossicular chain and extent of disease.
Binnetoglu A; Sari M; Baglam T; Erbarut Seven I; Yumusakhuylu AC; Topuz MF; Batman C
Clin Otolaryngol; 2015 Aug; 40(4):335-40. PubMed ID: 25581788
[TBL] [Abstract][Full Text] [Related]
23. [Is reuse of autologous ear ossicles in cholesteatoma or chronic suppurative otitis media justified?].
Peng JC; Hoppe F
Laryngorhinootologie; 1994 Jul; 73(7):375-80. PubMed ID: 7916783
[TBL] [Abstract][Full Text] [Related]
24. Different production of interleukin-1alpha, interleukin-1beta and interleukin-8 from cholesteatomatous and normal epithelium.
Chung JW; Yoon TH
Acta Otolaryngol; 1998 Jun; 118(3):386-91. PubMed ID: 9655214
[TBL] [Abstract][Full Text] [Related]
25. [Immunohistochemical basement membrane analysis of cholesteatoma epithelium].
Lang S; Nerlich A; Wiest I; Schreiner M
Laryngorhinootologie; 1994 Jul; 73(7):371-4. PubMed ID: 7916782
[TBL] [Abstract][Full Text] [Related]
26. Scanning Electron Microscopy in the Evaluation of Defects to the Ossicular Chain in the Course of Chronic Otitis Media.
Wiatr A; Swiezy K; Skladzien J; Wiatr M
Ear Nose Throat J; 2021 Jun; 100(5):NP248-NP255. PubMed ID: 31565971
[TBL] [Abstract][Full Text] [Related]
27. HB-EGF expression as a potential biomarker of acquired middle ear cholesteatoma.
Xie S; Wang X; Ren H; Liu X; Ren J; Liu W
Acta Otolaryngol; 2017 Aug; 137(8):797-802. PubMed ID: 28498080
[TBL] [Abstract][Full Text] [Related]
28. Epithelial invasion of intraossicular spaces.
Sadé J
J Laryngol Otol; 1972 Jan; 86(1):15-21. PubMed ID: 5007949
[No Abstract] [Full Text] [Related]
29. Quantitative analysis of interleukin-1-alpha gene expression in middle ear cholesteatoma.
Bujía J; Kim C; Boyle D; Hammer C; Firestein G; Kastenbauer E
Laryngoscope; 1996 Feb; 106(2 Pt 1):217-20. PubMed ID: 8583857
[TBL] [Abstract][Full Text] [Related]
30. Expressions of c-jun and p53 proteins in human middle ear cholesteatoma: relationship to keratinocyte proliferation, differentiation, and programmed cell death.
Shinoda H; Huang CC
Laryngoscope; 1995 Nov; 105(11):1232-7. PubMed ID: 7475882
[TBL] [Abstract][Full Text] [Related]
31. Activation of NLRP3 inflammasome in human middle ear cholesteatoma and chronic otitis media.
Kariya S; Okano M; Zhao P; Kataoka Y; Yoshinobu J; Maeda Y; Ishihara H; Higaki T; Nishizaki K
Acta Otolaryngol; 2016; 136(2):136-40. PubMed ID: 26457439
[TBL] [Abstract][Full Text] [Related]
32. Patterns of Bone Damage in Patients With Chronic Middle Ear Inflammation.
Wiatr A; Strek P; Wiatr M
Ear Nose Throat J; 2021 Dec; 100(10):NP438-NP443. PubMed ID: 32397813
[TBL] [Abstract][Full Text] [Related]
33. The nature of the epithelium in acquired cholesteatoma: Part 3--Cytokeratin patterns in aural epithelial and cholesteatoma cells grown in cell culture.
Lee RJ; Sidey C; Narula AA; James RF
Clin Otolaryngol Allied Sci; 1994 Dec; 19(6):516-20. PubMed ID: 7534665
[TBL] [Abstract][Full Text] [Related]
34. A study on epidermal proliferation ability in cholesteatoma.
Tanaka Y; Shiwa M; Kojima H; Miyazaki H; Kamide Y; Moriyama H
Laryngoscope; 1998 Apr; 108(4 Pt 1):537-42. PubMed ID: 9546266
[TBL] [Abstract][Full Text] [Related]
35. [Autocrine growth mechanisms of cholesteatoma epithelium].
Schilling V; Holly A; Bujía J; Schulz P
Laryngorhinootologie; 1993 Jul; 72(7):319-23. PubMed ID: 8369082
[TBL] [Abstract][Full Text] [Related]
36. [Epithelium-stroma interaction in cholesteatoma of the middle ear].
Jacob R; Welkoborsky HJ; Mann W
Laryngorhinootologie; 2001 Jan; 80(1):11-7. PubMed ID: 11272241
[TBL] [Abstract][Full Text] [Related]
37. [Possible role of transforming growth factor alpha on the cholesteatoma growth regulation].
Xu Y; Wu Z; Tao Z; Hua Q; Jin K
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Jan; 17(1):32-4. PubMed ID: 12725186
[TBL] [Abstract][Full Text] [Related]
38. Effect of intratympanic steroid application on the development of experimental cholesteatoma.
Sennaroglu L; Ozkul A; Gedikoglu G; Turan E
Laryngoscope; 1998 Apr; 108(4 Pt 1):543-7. PubMed ID: 9546267
[TBL] [Abstract][Full Text] [Related]
39. [Immunohistochemical studies with middle ear mucosal remnants in cholesteatoma].
Sudhoff H; Borkowski G; Bujia J; Hildmann H; Fisseler-Eckhoff A
HNO; 1997 Aug; 45(8):630-5. PubMed ID: 9378670
[TBL] [Abstract][Full Text] [Related]
40. Bone destruction mechanisms in chronic otitis media with cholesteatoma: specific production by cholesteatoma tissue in culture of bone-resorbing activity attributable to interleukin-1 alpha.
Kurihara A; Toshima M; Yuasa R; Takasaka T
Ann Otol Rhinol Laryngol; 1991 Dec; 100(12):989-98. PubMed ID: 1746847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
